Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 218 entries
Sorted by: Best Match Show Resources per page
Cretaceous stem chondrichthyans survived the end-Permian mass extinction

STEM and diversity

Adnet S, Cappetta H, Cavin L, Guinot G.
GSID: 3UWHS3pIOMUJ
G Guinot, S Adnet, L Cavin, H Cappetta - Nature communications, 2013 - nature.com

… (batoids) and in other stem chondrichthyan groups and hybodont … to the high stem chondrichthyan diversity and some of these … to most Carboniferous stem Chondrichthyan fossil …

Cite
Guinot, G., Adnet, S., Cavin, L., & Cappetta, H. (2013). Cretaceous stem chondrichthyans survived the end-Permian mass extinction. Nature communications, 4(1), 1-8.
Guinot, Guillaume, et al. "Cretaceous stem chondrichthyans survived the end-Permian mass extinction." Nature communications 4.1 (2013): 1-8.
Copy Download .nbib Format: MLA
Malaria exflagellation in a human peripheral blood smear.

IDCases

Arneth B, Keller C, Schaefer S.
PMID: 28924557
IDCases. 2017 Aug 24;10:51-52. doi: 10.1016/j.idcr.2017.08.010. eCollection 2017.

A clinical case is presented here of a patient from Afganistan. We found intraerythrocytic parasites consistent with malaria vivax. Additionally extraerythrocytic structures were seen. First a co-infection with Borrelia recurrentis was discussed later these structures were identified as male...

Cite
Arneth B, Keller C, Schaefer S. Malaria exflagellation in a human peripheral blood smear. IDCases. 2017;10:51-52doi: 10.1016/j.idcr.2017.08.010.
Arneth, B., Keller, C., & Schaefer, S. (2017). Malaria exflagellation in a human peripheral blood smear. IDCases, 1051-52. https://doi.org/10.1016/j.idcr.2017.08.010
Arneth, Borros, et al. "Malaria exflagellation in a human peripheral blood smear." IDCases vol. 10 (2017): 51-52. doi: https://doi.org/10.1016/j.idcr.2017.08.010
Arneth B, Keller C, Schaefer S. Malaria exflagellation in a human peripheral blood smear. IDCases. 2017 Aug 24;10:51-52. doi: 10.1016/j.idcr.2017.08.010. eCollection 2017. PMID: 28924557; PMCID: PMC5591384.
Copy Download .nbib Format: NLM
Erratum to "Intubation and extubation of the ICU patient" [Anaesth. Crit. Care Pain Med. 36 (5) (2017) 327-341].

Anaesthesia, critical care & pain medicine

Quintard H, l'Her E, Pottecher J, Adnet F, Constantin JM, De Jong A, Diemunsch P, Fesseau R, Freynet A, Girault C, Guitton C, Hamonic Y, Maury E, Mekontso-Dessap A, Michel F, Nolent P, Perbet S, Prat G, Roquilly A, Tazarourte K, Terzi N, Thille AW, Alves M, Gayat E, Donetti L.
PMID: 29578076
Anaesth Crit Care Pain Med. 2018 Jun;37(3):295-296. doi: 10.1016/j.accpm.2018.03.005. Epub 2018 Mar 22.

No abstract available.

Cite
Quintard H, l'Her E, Pottecher J, et al. Erratum to "Intubation and extubation of the ICU patient" [Anaesth. Crit. Care Pain Med. 36 (5) (2017) 327-341]. Anaesth Crit Care Pain Med. 2018;37(3):295-296doi: 10.1016/j.accpm.2018.03.005.
Quintard, H., l'Her, E., Pottecher, J., Adnet, F., Constantin, J. M., De Jong, A., Diemunsch, P., Fesseau, R., Freynet, A., Girault, C., Guitton, C., Hamonic, Y., Maury, E., Mekontso-Dessap, A., Michel, F., Nolent, P., Perbet, S., Prat, G., Roquilly, A., Tazarourte, K., Terzi, N., Thille, A. W., Alves, M., Gayat, E., & Donetti, L. (2018). Erratum to "Intubation and extubation of the ICU patient" [Anaesth. Crit. Care Pain Med. 36 (5) (2017) 327-341]. Anaesthesia, critical care & pain medicine, 37(3), 295-296. https://doi.org/10.1016/j.accpm.2018.03.005
Quintard, H, et al. "Erratum to "Intubation and extubation of the ICU patient" [Anaesth. Crit. Care Pain Med. 36 (5) (2017) 327-341]." Anaesthesia, critical care & pain medicine vol. 37,3 (2018): 295-296. doi: https://doi.org/10.1016/j.accpm.2018.03.005
Quintard H, l'Her E, Pottecher J, Adnet F, Constantin JM, De Jong A, Diemunsch P, Fesseau R, Freynet A, Girault C, Guitton C, Hamonic Y, Maury E, Mekontso-Dessap A, Michel F, Nolent P, Perbet S, Prat G, Roquilly A, Tazarourte K, Terzi N, Thille AW, Alves M, Gayat E, Donetti L. Erratum to "Intubation and extubation of the ICU patient" [Anaesth. Crit. Care Pain Med. 36 (5) (2017) 327-341]. Anaesth Crit Care Pain Med. 2018 Jun;37(3):295-296. doi: 10.1016/j.accpm.2018.03.005. Epub 2018 Mar 22. PMID: 29578076.
Copy Download .nbib Format: NLM
Impact of an Electronic Monitoring Intervention to Improve Adherence to Inhaled Medication in Patients with Asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial.

JMIR research protocols

Gregoriano C, Dieterle T, Dürr S, Arnet I, Hersberger KE, Leuppi JD.
PMID: 29061556
JMIR Res Protoc. 2017 Oct 23;6(10):e204. doi: 10.2196/resprot.7522.

BACKGROUND: Despite progress in pharmacological and non-pharmacological treatment in recent years, the burden of disease among patients with asthma and chronic obstructive pulmonary disease (COPD) is high and patients are frequently hospitalized due to exacerbations. Reasons for uncontrolled diseases...

Cite
Gregoriano C, Dieterle T, Dürr S, et al. Impact of an Electronic Monitoring Intervention to Improve Adherence to Inhaled Medication in Patients with Asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2017;6(10):e204doi: 10.2196/resprot.7522.
Gregoriano, C., Dieterle, T., Dürr, S., Arnet, I., Hersberger, K. E., & Leuppi, J. D. (2017). Impact of an Electronic Monitoring Intervention to Improve Adherence to Inhaled Medication in Patients with Asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial. JMIR research protocols, 6(10), e204. https://doi.org/10.2196/resprot.7522
Gregoriano, Claudia, et al. "Impact of an Electronic Monitoring Intervention to Improve Adherence to Inhaled Medication in Patients with Asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial." JMIR research protocols vol. 6,10 (2017): e204. doi: https://doi.org/10.2196/resprot.7522
Gregoriano C, Dieterle T, Dürr S, Arnet I, Hersberger KE, Leuppi JD. Impact of an Electronic Monitoring Intervention to Improve Adherence to Inhaled Medication in Patients with Asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2017 Oct 23;6(10):e204. doi: 10.2196/resprot.7522. PMID: 29061556; PMCID: PMC5673887.
Copy Download .nbib Format: NLM
Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus.

Endocrine connections

Arneth B.
PMID: 28986401
Endocr Connect. 2017 Nov;6(8):758-765. doi: 10.1530/EC-17-0230. Epub 2017 Oct 06.

BACKGROUND: The origin of autoimmune disease type 1 diabetes is still unknown.AIM: This study assessed the activation of CD4+ and CD8+ T-lymphocytes by human insulin and human glutamate decarboxylase (GAD) in patients with type 1 or type 2 diabetes...

Cite
Arneth B. Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus. Endocr Connect. 2017;6(8):758-765doi: 10.1530/EC-17-0230.
Arneth, B. (2017). Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus. Endocrine connections, 6(8), 758-765. https://doi.org/10.1530/EC-17-0230
Arneth, Borros. "Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus." Endocrine connections vol. 6,8 (2017): 758-765. doi: https://doi.org/10.1530/EC-17-0230
Arneth B. Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus. Endocr Connect. 2017 Nov;6(8):758-765. doi: 10.1530/EC-17-0230. Epub 2017 Oct 06. PMID: 28986401; PMCID: PMC5670273.
Copy Download .nbib Format: NLM
Spectromicroscopic insights for rational design of redox-based memristive devices.

Nature communications

Baeumer C, Schmitz C, Ramadan AH, Du H, Skaja K, Feyer V, Müller P, Arndt B, Jia CL, Mayer J, De Souza RA, Michael Schneider C, Waser R, Dittmann R.
PMID: 26477940
Nat Commun. 2015 Oct 19;6:8610. doi: 10.1038/ncomms9610.

The demand for highly scalable, low-power devices for data storage and logic operations is strongly stimulating research into resistive switching as a novel concept for future non-volatile memory devices. To meet technological requirements, it is imperative to have a...

Cite
Baeumer C, Schmitz C, Ramadan AH, et al. Spectromicroscopic insights for rational design of redox-based memristive devices. Nat Commun. 2015;6:8610doi: 10.1038/ncomms9610.
Baeumer, C., Schmitz, C., Ramadan, A. H., Du, H., Skaja, K., Feyer, V., Müller, P., Arndt, B., Jia, C. L., Mayer, J., De Souza, R. A., Michael Schneider, C., Waser, R., & Dittmann, R. (2015). Spectromicroscopic insights for rational design of redox-based memristive devices. Nature communications, 68610. https://doi.org/10.1038/ncomms9610
Baeumer, Christoph, et al. "Spectromicroscopic insights for rational design of redox-based memristive devices." Nature communications vol. 6 (2015): 8610. doi: https://doi.org/10.1038/ncomms9610
Baeumer C, Schmitz C, Ramadan AH, Du H, Skaja K, Feyer V, Müller P, Arndt B, Jia CL, Mayer J, De Souza RA, Michael Schneider C, Waser R, Dittmann R. Spectromicroscopic insights for rational design of redox-based memristive devices. Nat Commun. 2015 Oct 19;6:8610. doi: 10.1038/ncomms9610. PMID: 26477940; PMCID: PMC4634325.
Copy Download .nbib Format: NLM
Context and wine quality effects on consumers' mood, emotions, liking and willingness to pay for Australian Shiraz wines.

Food research international (Ottawa, Ont.)

Danner L, Ristic R, Johnson TE, Meiselman HL, Hoek AC, Jeffery DW, Bastian SEP.
PMID: 28460912
Food Res Int. 2016 Nov;89:254-265. doi: 10.1016/j.foodres.2016.08.006. Epub 2016 Aug 08.

This study investigated the effect of different contexts on consumers' mood, product-evoked emotions, liking and willingness to pay for wine. Three consumer trials (n=114, 115, and 120) examined 3 different sample sets of 4 Australian commercial Shiraz wines. Each...

Cite
Danner L, Ristic R, Johnson TE, et al. Context and wine quality effects on consumers' mood, emotions, liking and willingness to pay for Australian Shiraz wines. Food Res Int. 2016;89:254-265doi: 10.1016/j.foodres.2016.08.006.
Danner, L., Ristic, R., Johnson, T. E., Meiselman, H. L., Hoek, A. C., Jeffery, D. W., & Bastian, S. E. P. (2016). Context and wine quality effects on consumers' mood, emotions, liking and willingness to pay for Australian Shiraz wines. Food research international (Ottawa, Ont.), 89254-265. https://doi.org/10.1016/j.foodres.2016.08.006
Danner, Lukas, et al. "Context and wine quality effects on consumers' mood, emotions, liking and willingness to pay for Australian Shiraz wines." Food research international (Ottawa, Ont.) vol. 89 (2016): 254-265. doi: https://doi.org/10.1016/j.foodres.2016.08.006
Danner L, Ristic R, Johnson TE, Meiselman HL, Hoek AC, Jeffery DW, Bastian SEP. Context and wine quality effects on consumers' mood, emotions, liking and willingness to pay for Australian Shiraz wines. Food Res Int. 2016 Nov;89:254-265. doi: 10.1016/j.foodres.2016.08.006. Epub 2016 Aug 08. PMID: 28460912.
Copy Download .nbib Format: NLM
Pattern of timing adherence could guide recommendations for personalized intake schedules.

Journal of personalized medicine

Walter P, Arnet I, Romanens M, Tsakiris DA, Hersberger KE.
PMID: 25562364
J Pers Med. 2012 Nov 28;2(4):267-76. doi: 10.3390/jpm2040267.

Deviations in execution from the prescribed drug intake schedules (timing non adherence) are frequent and may pose a substantial risk for therapeutic failure. Simple methods to monitor timing adherence with multiple drugs are missing. A new technology, i.e., the...

Cite
Walter P, Arnet I, Romanens M, et al. Pattern of timing adherence could guide recommendations for personalized intake schedules. J Pers Med. 2012;2(4):267-76doi: 10.3390/jpm2040267.
Walter, P., Arnet, I., Romanens, M., Tsakiris, D. A., & Hersberger, K. E. (2012). Pattern of timing adherence could guide recommendations for personalized intake schedules. Journal of personalized medicine, 2(4), 267-76. https://doi.org/10.3390/jpm2040267
Walter, Philipp, et al. "Pattern of timing adherence could guide recommendations for personalized intake schedules." Journal of personalized medicine vol. 2,4 (2012): 267-76. doi: https://doi.org/10.3390/jpm2040267
Walter P, Arnet I, Romanens M, Tsakiris DA, Hersberger KE. Pattern of timing adherence could guide recommendations for personalized intake schedules. J Pers Med. 2012 Nov 28;2(4):267-76. doi: 10.3390/jpm2040267. PMID: 25562364; PMCID: PMC4251372.
Copy Download .nbib Format: NLM
Adherence counseling during patient contacts in swiss community pharmacies.

Patient preference and adherence

Boeni F, Arnet I, Hersberger KE.
PMID: 25960642
Patient Prefer Adherence. 2015 Apr 24;9:597-605. doi: 10.2147/PPA.S76027. eCollection 2015.

PURPOSE: Numerous studies showed the effectiveness of pharmaceutical care in improving medication adherence in primary care patients. However, in daily pharmacy practice, the provision of pharmaceutical care appears to be limited. We aimed at quantifying the content of counseling...

Cite
Boeni F, Arnet I, Hersberger KE. Adherence counseling during patient contacts in swiss community pharmacies. Patient Prefer Adherence. 2015;9:597-605doi: 10.2147/PPA.S76027.
Boeni, F., Arnet, I., & Hersberger, K. E. (2015). Adherence counseling during patient contacts in swiss community pharmacies. Patient preference and adherence, 9597-605. https://doi.org/10.2147/PPA.S76027
Boeni, Fabienne, et al. "Adherence counseling during patient contacts in swiss community pharmacies." Patient preference and adherence vol. 9 (2015): 597-605. doi: https://doi.org/10.2147/PPA.S76027
Boeni F, Arnet I, Hersberger KE. Adherence counseling during patient contacts in swiss community pharmacies. Patient Prefer Adherence. 2015 Apr 24;9:597-605. doi: 10.2147/PPA.S76027. eCollection 2015. PMID: 25960642; PMCID: PMC4423509.
Copy Download .nbib Format: NLM
Resistive Switching Mechanisms on TaOx and SrRuO3 Thin-Film Surfaces Probed by Scanning Tunneling Microscopy.

ACS nano

Moors M, Adepalli KK, Lu Q, Wedig A, Bäumer C, Skaja K, Arndt B, Tuller HL, Dittmann R, Waser R, Yildiz B, Valov I.
PMID: 26738414
ACS Nano. 2016 Jan 26;10(1):1481-92. doi: 10.1021/acsnano.5b07020. Epub 2016 Jan 12.

The local electronic properties of tantalum oxide (TaOx, 2 ≤ x ≤ 2.5) and strontium ruthenate (SrRuO3) thin-film surfaces were studied under the influence of electric fields induced by a scanning tunneling microscope (STM) tip. The switching between different...

Cite
Moors M, Adepalli KK, Lu Q, et al. Resistive Switching Mechanisms on TaOx and SrRuO3 Thin-Film Surfaces Probed by Scanning Tunneling Microscopy. ACS Nano. 2016;10(1):1481-92doi: 10.1021/acsnano.5b07020.
Moors, M., Adepalli, K. K., Lu, Q., Wedig, A., Bäumer, C., Skaja, K., Arndt, B., Tuller, H. L., Dittmann, R., Waser, R., Yildiz, B., & Valov, I. (2016). Resistive Switching Mechanisms on TaOx and SrRuO3 Thin-Film Surfaces Probed by Scanning Tunneling Microscopy. ACS nano, 10(1), 1481-92. https://doi.org/10.1021/acsnano.5b07020
Moors, Marco, et al. "Resistive Switching Mechanisms on TaOx and SrRuO3 Thin-Film Surfaces Probed by Scanning Tunneling Microscopy." ACS nano vol. 10,1 (2016): 1481-92. doi: https://doi.org/10.1021/acsnano.5b07020
Moors M, Adepalli KK, Lu Q, Wedig A, Bäumer C, Skaja K, Arndt B, Tuller HL, Dittmann R, Waser R, Yildiz B, Valov I. Resistive Switching Mechanisms on TaOx and SrRuO3 Thin-Film Surfaces Probed by Scanning Tunneling Microscopy. ACS Nano. 2016 Jan 26;10(1):1481-92. doi: 10.1021/acsnano.5b07020. Epub 2016 Jan 12. PMID: 26738414.
Copy Download .nbib Format: NLM
Targeted Removal of Bioavailable Metal as a Detoxification Strategy for Carbon Nanotubes.

Carbon

Liu X, Guo L, Morris D, Kane AB, Hurt RH.
PMID: 19255622
Carbon N Y. 2008 Mar;46(3):489-500. doi: 10.1016/j.carbon.2007.12.018.

There is substantial evidence for toxicity and/or carcinogenicity upon inhalation of pure transition metals in fine particulate form. Carbon nanotube catalyst residues may trigger similar metal-mediated toxicity, but only if the metal is bioavailable and not fully encapsulated within...

Cite
Liu X, Guo L, Morris D, et al. Targeted Removal of Bioavailable Metal as a Detoxification Strategy for Carbon Nanotubes. Carbon N Y. 2008;46(3):489-500doi: 10.1016/j.carbon.2007.12.018.
Liu, X., Guo, L., Morris, D., Kane, A. B., & Hurt, R. H. (2008). Targeted Removal of Bioavailable Metal as a Detoxification Strategy for Carbon Nanotubes. Carbon, 46(3), 489-500. https://doi.org/10.1016/j.carbon.2007.12.018
Liu, Xinyuan, et al. "Targeted Removal of Bioavailable Metal as a Detoxification Strategy for Carbon Nanotubes." Carbon vol. 46,3 (2008): 489-500. doi: https://doi.org/10.1016/j.carbon.2007.12.018
Liu X, Guo L, Morris D, Kane AB, Hurt RH. Targeted Removal of Bioavailable Metal as a Detoxification Strategy for Carbon Nanotubes. Carbon N Y. 2008 Mar;46(3):489-500. doi: 10.1016/j.carbon.2007.12.018. PMID: 19255622; PMCID: PMC2614279.
Copy Download .nbib Format: NLM
Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis.

Nephron extra

Takagi N, Tanizawa T, Kon V, Fogo AB, Ichikawa I, Ma J.
PMID: 22479265
Nephron Extra. 2012 Jan;2(1):17-26. doi: 10.1159/000334961. Epub 2012 Jan 31.

BACKGROUND: We previously showed that angiotensin type 1 receptor (AT1) blocker (ARB) attenuates glomerular injury in Nphs1-hCD25 (NEP25) transgenic mice, a model of selective podocyte injury. However, subsequent studies in NEP25 mice with podocyte-specific deficiency of AT1 revealed that...

Cite
Takagi N, Tanizawa T, Kon V, et al. Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis. Nephron Extra. 2012;2(1):17-26doi: 10.1159/000334961.
Takagi, N., Tanizawa, T., Kon, V., Fogo, A. B., Ichikawa, I., & Ma, J. (2012). Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis. Nephron extra, 2(1), 17-26. https://doi.org/10.1159/000334961
Takagi, Nobuaki, et al. "Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis." Nephron extra vol. 2,1 (2012): 17-26. doi: https://doi.org/10.1159/000334961
Takagi N, Tanizawa T, Kon V, Fogo AB, Ichikawa I, Ma J. Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis. Nephron Extra. 2012 Jan;2(1):17-26. doi: 10.1159/000334961. Epub 2012 Jan 31. PMID: 22479265; PMCID: PMC3318935.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 218 entries